(IN BRIEF) The European Commission has approved Theralugand®, Eckert & Ziegler’s high-purity Lutetium-177 chloride, for routine clinical use across the European Economic Area. This approval allows its application in targeted cancer therapies, such as for neuroendocrine tumors and metastatic prostate … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Cancer Therapies, Dr. Harald Hasselmann, Eckert & Ziegler, EU, Healthcare, safety, Theralugand®, wellness
(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The solution provides a convenient, twice-daily alternative to tablets, … Read the full press release
(IN BRIEF) Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an adjuvant treatment for high-risk hormone receptor-positive (HR+), HER2-negative early breast cancer (EBC). The approval, based on the Phase III NATALEE trial, … Read the full press release
(IN BRIEF) The University of Southampton is leading a collaboration within the £50 million NIHR Challenge: Maternity Disparities consortium to address inequalities in maternity care across the UK. The initiative aims to improve health outcomes by focusing on preconception and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Society, Technology, United Kingdom
Tagged Gillian Merron, Healthcare, Margaret Beattie, Maternity Care Disparities, partnership, poverty, Professor Keith Godfrey, racism, society, University of Southampton
(IN BRIEF) A study by researchers from China and the UK has identified a link between depression and menstrual pain (dysmenorrhea), suggesting depression may cause rather than result from period pain. Using Mendelian randomisation, the team analyzed genetic data from … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged depression, Dr. Dan Carr, Dr. Zhen Wei, Healthcare, Menstrual Pain, partnership, Professor John Moraros, Shuhe Liu, University of Liverpool, Xi’an Jiaotong-Liverpool University
(IN BRIEF) Researchers at the University of Liverpool have identified a new mechanism in Alzheimer’s disease involving the interaction between Amyloid Precursor Protein (APP) and talin, a synaptic scaffold protein. This study reveals that disruptions in this mechanical signaling pathway … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Alzheimer’s disease, Professor Ben Goult, University of Liverpool
(IN BRIEF) Philips expands its partnership with AWS to offer cloud-based diagnostic solutions that streamline workflows and improve patient outcomes across multiple healthcare specialties. The integration of generative AI will enable clinicians to work more efficiently, freeing up valuable time … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Technology
Tagged aws, Cloud-Based Diagnostics, Edward Steiner, generative AI, Healthcare Efficiency, Matt Garman, partnership, Philips, Roy Jakobs, sustainability, USA
(IN BRIEF) Roche has announced the acquisition of Poseida Therapeutics, a clinical-stage biopharmaceutical company specializing in off-the-shelf CAR-T cell therapies, for $9.00 per share in cash, totaling approximately $1 billion. Poseida stockholders may also receive up to $4.00 per share … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged acquisition, Aviv Regev, cell therapy, INNOVATION, Levi Garraway, partnership, Poseida Therapeutics, Roche, sustainability, USA
(IN BRIEF) Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for patients with PD-L1-high, advanced, or metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of improving … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Lung Cancer Therapy, Roche, safety, SKYSCRAPER-01 Study, TECENTRIQ, Tiragolumab
(IN BRIEF) The Liverpool City Region Combined Authority has launched the Health Tech Business Incubation Centre (Health BIC) at STFC Daresbury Laboratory, backed by £1.8 million from the Life Sciences Innovation Zone Programme. Designed to support health and life sciences … Read the full press release
(IN BRIEF) Sweco has been commissioned by Region Norrbotten to design and plan a new regional hospital as part of Kiruna’s relocation three kilometers east due to the expansion of its iron ore mine. The hospital, expected to be completed … Read the full press release
(IN BRIEF) Symrise, a global leader in health and nutrition solutions, has made a public cash offer to acquire the remaining shares of Probi AB, a biotics solutions company listed on Nasdaq Stockholm. Already holding a 69.7% stake in Probi, … Read the full press release
Posted in Business, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged acquisition, Health Solutions, Heinz-Jürgen Bertram, ownership, partnership, Probi AB, Stockholm, sustainability, Symrise
(IN BRIEF) Fresenius Kabi is addressing the global threat of antimicrobial resistance (AMR), which causes millions of deaths annually, through sustainable manufacturing, improved antibiotic access, and promoting responsible use. During AMR Awareness Week, the company highlighted its commitment to reducing … Read the full press release
(IN BRIEF) Research published in the European Heart Journal reveals that combining anticoagulants with NSAIDs, such as ibuprofen, diclofenac, or naproxen, significantly increases the risk of internal bleeding. The study, involving over 51,000 patients in Denmark, found that the bleeding … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Anticoagulants, diclofenac, Elevated Bleeding, ESC, Healthcare, ibuprofen, naproxen, NSAIDs, Professor Robert F. Storey, rivaroxaban, Søren Riis Petersen, warfarin
(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) with EGFR mutations who have not experienced disease progression after platinum-based chemoradiation therapy. This … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Manuel Cobo, safety, Susan Galbraith, Tagrisso, therapy, Unresectable EGFR-Mutated Lung Cancer
(IN BRIEF) The European Investment Bank (EIB) has provided an initial €100 million loan for the construction of the €1 billion Laakso Joint Hospital in Helsinki, which will integrate psychiatric, neurological, geriatric, and palliative care services for 1.7 million Uusimaa … Read the full press release
Posted in Banks, Business, Construction, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Real Estate, Technology
Tagged EIB, Helsinki, Laakso Joint Hospital Project, Marko Virtanen, partnership, sustainability, Thomas Östros
(IN BRIEF) In his doctoral research at the University of Helsinki, Matej Zore demonstrated the potential of repurposing the drugs fingolimod and etrasimod, originally developed for autoimmune diseases, to combat antimicrobial resistance (AMR). These drugs showed notable efficacy against drug-resistant … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged antimicrobial resistance, etrasimod, fingolimod, Matej Zore, methicillin-resistant Staphylococcus aureus (MRSA), Professor Fredrik Almqvist, Professor Jari Yli-Kauhaluoma, Repurposing Drugs, University of Helsinki, vancomycin-resistant Enterococcus (VRE)
(IN BRIEF) Alder Hey Children’s NHS Foundation Trust has secured £1.1 million from the NIHR to upgrade its advanced 3T research MRI scanner, strengthening its partnership with the University of Liverpool in pediatric health research. Matched funding for ophthalmology equipment … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Non Profit, Science, Technology, United Kingdom
Tagged Alder Hey Children's Hospital, Alder Hey Children’s NHS Foundation Trust, charity, Children Growing Up in Liverpool (C-GULL), Dr. Dan Hawcutt, NIHR Funding, partnership, Pediatric Health Research, sustainability, University of Liverpool, wellness, Wes Streeting
(IN BRIEF) MDC has completed the acquisition of Lighteum, a leader in nitinol-based medical component manufacturing, expanding its capabilities in the medical device industry. The acquisition combines MDC’s expertise in platinum group metals and micromachining with Lighteum’s advanced nitinol processing … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Technology, United Kingdom
Tagged acquisition, Adrien Sassi, Don Freeman, Healthcare, INNOVATION, leadership, Lighteum, Lorie Lodico IV, MDC, Medical Device Manufacturing, Montagu, partnership
(IN BRIEF) Henkel and Linxens are collaborating to advance printed electronics for medical wearables, debuting a skin patch concept featuring self-regulating heating elements designed to enhance patient comfort. The innovation, ideal for applications like pain relief and temperature-regulated drug delivery, … Read the full press release
Posted in Chemicals, Germany, Healthcare, Pharma & Biotech
Tagged biosensors, carbon resistive inks, conductive inks, connectivity, flexible circuits, Healthcare, Henkel, INNOVATION, IoT, Linxens, Linxens Healthcare, Loctite portfolio, MEDICA trade show, medical wearables, Minh Lê, pain relief, patient comfort, Pia Schmiedel, Positive Temperature Coefficient inks, printed electronics, resistive inks, Roll-to-Roll screen printing, self-regulating heating elements, silver conductive inks, skin patches, temperature-controlled drug delivery
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?